EGFR and neoplasm: Treatment of athymic mice engrafted with EGFR-dependent colon cancers, including HCA-7, DLD-1, and HT-29 with Herceptin® showed tumor regression and decreased EGFR tyrosine phosphorylation in tumor cells [95].